LSD Targeting Peptide (CAT#: OLY-1025-YS-2)

Description

LSD is a peptide-based agent demonstrating selective targeting specificity toward melanoma-derived lymphatic endothelial cells (LECs) in C8161 models, without cross-reactivity to normal tissue lymphatics. Conjugation with pro-apoptotic peptides has been used to study the reduction of tumor lymphatic density in vivo. This peptide serves as a specialized tool for investigating lymphatic-specific molecular interactions and pathways in oncological research models.

Molecular Weight

1009.20

Purity

> 95%

Formula

C₃₉H₇₂N₁₄O₁₃S₂

Product Type

Targeting Peptide

Sequence

Cys-Leu-Ser-Asp-Gly-Lys-Arg-Lys-Cys

Form (20 deg.C)

Solid

Storage Condition

Store sealed at -20°C, away from moisture.